26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Red blood cell distribution width as a predictor of atrial fibrillation

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="jcla22378-sec-0001"> <!-- named anchor --> </a> <h5 class="section-title" id="d1193981e341">Background</h5> <p id="d1193981e343">Current evidence suggests that a higher red blood cell distribution width ( <span style="fixed-case">RDW</span>) may be associated with increased risk of atrial fibrillation ( <span style="fixed-case">AF</span>) development. Given that some controversial results have been published, we conducted a systematic review of the current literature along with a comprehensive meta‐analysis to evaluate the association between <span style="fixed-case">RDW</span> and <span style="fixed-case">AF</span> development. </p> </div><div class="section"> <a class="named-anchor" id="jcla22378-sec-0002"> <!-- named anchor --> </a> <h5 class="section-title" id="d1193981e358">Methods</h5> <p id="d1193981e360">We performed a systematic search of the literature using electronic databases (PubMed, Ovid, Embase, and Web of Science) to identify studies reporting on the association between <span style="fixed-case">RDW</span> and <span style="fixed-case">AF</span> development published until June 2016. We used both fix‐effects and random‐effects models to calculate the overall effect estimate. An <i>I</i> <sup>2</sup> &gt; 50% indicates at least moderate statistical heterogeneity. A sensitivity analysis and subgroup analysis were performed to find the origin of heterogeneity. </p> </div><div class="section"> <a class="named-anchor" id="jcla22378-sec-0003"> <!-- named anchor --> </a> <h5 class="section-title" id="d1193981e375">Results</h5> <p id="d1193981e377">A total of 12 studies involving 2721 participants were included in this meta‐analysis. The standardized mean difference in the <span style="fixed-case">RDW</span> levels between patients with and those without <span style="fixed-case">AF</span> development was 0.66 units ( <i>P</i> &lt; .05; 95% confidence interval 0.44‐0.88). A significant heterogeneity between the individual studies was observed ( <i>P</i> &lt; .05; <i>I</i> <sup>2</sup> = 80.4%). A significant association between the baseline <span style="fixed-case">RDW</span> levels and <span style="fixed-case">AF</span> occurrence or recurrence following cardiac procedure or surgery was evident ( <span style="fixed-case">SMD</span>: 0.61; 95% confidence interval 0.33‐0.88; <i>P</i> &lt; .05) with significant heterogeneity across the studies ( <i>I</i> <sup>2</sup> = 80.7%; <i>P</i> &lt; .01). </p> </div><div class="section"> <a class="named-anchor" id="jcla22378-sec-0004"> <!-- named anchor --> </a> <h5 class="section-title" id="d1193981e421">Conclusions</h5> <p id="d1193981e423">Our comprehensive meta‐analysis suggests that higher levels of <span style="fixed-case">RDW</span> are associated with an increased risk of <span style="fixed-case">AF</span> in different populations. </p> </div>

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease.

          BACKGROUND: Higher levels of red blood cell distribution width (RDW) may be associated with adverse outcomes in patients with heart failure. We examined the association between RDW and the risk of all-cause mortality and adverse cardiovascular outcomes in a population of people with coronary disease who were free of heart failure at baseline. METHODS AND RESULTS: We performed a post hoc analysis of data from the Cholesterol and Recurrent Events study. Baseline RDW was measured in 4111 participants who were randomized to receive pravastatin 40 mg daily or placebo and followed for a median of 59.7 months. We used Cox proportional hazards models to examine the association between RDW and adverse clinical outcomes. During nearly 60 months of follow-up, 376 participants died. A significant association was noted between baseline RDW level and the adjusted risk of all-cause mortality (hazard ratio per percent increase in RDW, 1.14; 95% confidence interval, 1.05 to 1.24). After categorization based on quartile of baseline RDW and further adjustment for hematocrit and other cardiovascular risk factors, a graded independent relation between RDW and death was observed (P for trend=0.001). For instance, participants with RDW in the highest quartile had an adjusted hazard ratio for death of 1.78 (95% confidence interval, 1.28 to 2.47) compared with those in the lowest quartile. Higher levels of RDW were also associated with increased risk of coronary death/nonfatal myocardial infarction, new symptomatic heart failure, and stroke. CONCLUSIONS: We found a graded independent relation between higher levels of RDW and the risk of death and cardiovascular events in people with prior myocardial infarction but no symptomatic heart failure at baseline.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis.

            We conducted a systematic review and meta-analysis of observational studies to examine the association between baseline C-reactive protein (CRP) levels and the recurrence of atrial fibrillation (AF) after successful electrical cardioversion (EC). Current evidence links AF to the inflammatory state. Inflammatory indexes such as CRP have been related to the development and persistence of AF. However, inconsistent results have been published with regard to the role of CRP in predicting sinus rhythm maintenance after successful EC. Using PubMed, the Cochrane clinical trials database, and EMBASE, we searched for literature published June 2006 or earlier. In addition, a manual search was performed using all review articles on this topic, reference lists of papers, and abstracts from conference reports. Of the 225 initially identified studies, 7 prospective observational studies with 420 patients (229 with and 191 without AF relapse) were finally analyzed. Overall, baseline CRP levels were greater in patients with AF recurrence. The standardized mean difference in the CRP levels between the patients with, and those without AF was 0.35 units (95% confidence interval 0.01 to 0.69); test for overall effect z-score = 2.00 (p = 0.05). The heterogeneity test showed that there were significant differences between individual studies (p = 0.02; I(2) = 60.2%). Further analysis revealed that differences between the CRP assays possibly account for this heterogeneity. Our meta-analysis suggests that increased CRP levels are associated with greater risk of AF recurrence, although there was significant heterogeneity across the studies. The use of CRP levels in predicting sinus rhythm maintenance appears promising but requires further study.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease.

              Increased red blood cell (RBC) volume variation (RDW) has recently been shown to predict a wide range of mortality and morbidity: death due to cardiovascular disease, cancer, infection, renal disease, and more; complications in heart failure and coronary artery disease, advanced stage and worse prognosis in many cancers, poor outcomes in autoimmune disease, and many more. The mechanisms by which all of these diseases lead to increased RDW are unknown. Here we use a semi-mechanistic mathematical model of in vivo RBC population dynamics to dissect the factors controlling RDW and show that elevated RDW results largely from a slight reduction in the in vivo rate of RBC turnover. RBCs become smaller as they age, and a slight reduction in the rate of RBC turnover allows smaller cells to continue circulating, expanding the low-volume tail of the RBC population's volume distribution, and thereby increasing RDW. Our results show that mildly extended RBC lifespan is a previously unrecognized homeostatic adaptation common to a very wide range of pathologic states, likely compensating for subtle reductions in erythropoietic output. A mathematical model-based estimate of the clearance rate may provide a novel early-warning biomarker for a wide range of morbidity and mortality.
                Bookmark

                Author and article information

                Journal
                Journal of Clinical Laboratory Analysis
                J Clin Lab Anal
                Wiley
                08878013
                June 2018
                June 2018
                January 08 2018
                : 32
                : 5
                : e22378
                Affiliations
                [1 ]Department of Cardiology; Tianjin Institute of Cardiology; Second Hospital of Tianjin Medical University; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease; Tianjin China
                [2 ]First Department of Cardiology; University Hospital of Ioannina; Ioannina Greece
                [3 ]Second Department of Cardiology; Laboratory of Cardiac Electrophysiology; “Evangelismos” General Hospital of Athens; Athens Greece
                [4 ]Department of Medicine and Therapeutics; Chinese University of Hong Kong; Hong Kong, SAR China
                [5 ]Li Ka Shing Institute of Health Sciences; Chinese University of Hong Kong; Hong Kong, SAR China
                [6 ]Department of Internal Medicine; Shanghai First People's Hospital; Shanghai Jiao Tong University; Shanghai China
                Article
                10.1002/jcla.22378
                6817116
                29315856
                4d042966-701a-4e17-81a2-2b0b834a9869
                © 2018

                http://doi.wiley.com/10.1002/tdm_license_1.1

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article

                scite_
                31
                2
                32
                0
                Smart Citations
                31
                2
                32
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content1,656

                Cited by15